Flemming Forsberg: Clinical Trials

1 trial sponsored by Flemming Forsberg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1
Phase 21Active not recruiting 1

Follow Flemming Forsberg: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer
Gemcitabine Hydrochloride, Nab-paclitaxel, Fluorouracil - Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma
Phase 1 / Phase 2Active not recruitingFlemming Forsberg1202021-12-062025-11-04

Conditions studied

Pancreatic Neoplasms (1)

Interventions

130-nm albumin-bound paclitaxel (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Fluorouracil (1)  ·  Gemcitabine (1)  ·  Irinotecan (1)  ·  Leucovorin (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Oxaliplatin (1)  ·  Taxes (1)  ·  X-Rays (1)  ·  dehydroftorafur (1)

Countries

Norway (1)  ·  United States (1)

Results publications

PMID 41133726

NIH funding

R01CA199646 (1)